摘要
目的:探讨血塞通在老年人急性脑梗死治疗中的临床应用价值。方法:将本院2011年1月~2011年12月在本院诊治的82例急性脑梗死患者随机分成2组:①实验组41例;②对照组41例。对照组单纯给予阿托伐他汀治疗;实验组给予阿托伐他汀+血塞通治疗。观察比较两组的临床疗效、血凝系统和血液流变学的变化情况。结果:实验组的总有效率为82.93%,对照组的总有效率为56.09%,实验组的临床疗效明显优于对照组(P<0.05);实验组患者治疗后的Fbg、TT、PT、INR、APTT指标水平均显著性优于对照组(P<0.05);实验组患者治疗后的高切ηb、低切ηb、FIB、ηp、HCT指标水平均显著性优于对照组(P<0.05)。结论:临床应用血塞通治疗急性脑梗死的效果显著。
Objective:To investigate the clinical value about Xuesaitong for the treatment of elderly patients with acute cerebral infarction.Methods:The 82 cases of elderly acute cerebral infarction patients admitted to hospital from January 2010 to December 2011 were randomly divided into two groups,control group(n=41) and treatment group(n=41).The control group was treated with atorvastatin only,but the treatment group was treated with atorvastatin and Xuesaitong.The clinical effects,the changes of coagulation system and hemorheological in 2 groups was observed and compared.Results:The total effective rate was 82.93% in the treatment group,but the control group was 56.09%,so the clinical effects in the treatment group was significantly better than the control group(P0.05);the index value of Fbg,TT,PT,INR,APTT in the treatment group after treated were significantly better than the control group(P0.05);the index value of ηb,FIB,ηp,HCT in the treatment group after treated were significantly better than the control group(P0.05).Conclusion:There is a significant clinical effect of Xuesaitong for the treatment of elderly patients with acute cerebral infarction.
出处
《中国医药导刊》
2013年第1期114-115,共2页
Chinese Journal of Medicinal Guide
关键词
急性脑梗死
血塞通
临床价值
Acute cerebral infarction
Xuesaitong
Clinical value